USD 6.32 billion
Human Growth Hormone Market Size, Share, and Growth Analysis
Human Growth Hormone Market By Product (Long Acting, Others), By Application (Growth Hormone (GH) Deficiency, Adult GH Deficiency), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2308 |
Region:
Global |
Published Date: May, 2025
Pages:
219
|Tables:
68
|Figures:
75
Format -
Human Growth Hormone Market Insights
Global Human Growth Hormone Market size was valued at USD 6.32 billion in 2023 and is poised to grow from USD 7.1 billion in 2024 to USD 17.95 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).
The global human growth hormone industry is growing due to the evolution of clinical practice guidelines for treating human growth hormone deficiency. Additionally propelling market growth are developments in recombinant human growth hormone therapies. The market is growing as a result of increased accessibility to treatments and universal awareness of human growth hormone insufficiency. Governments and health organizations around the world are advocating early detection of illness through awareness programmes. A number of major companies across the globe are investing in research and development funds to come up with growth hormones with less side effects.
In order to increase their market equity, they also focus on the current trends in the human growth hormone sector and work on the effective treatment of any conditions related to hormones that promote growth. Development, tissue regeneration, and cell division processes are controlled by the human growth hormone or HGH. It is a peptide hormone of some sort that controls the body's cell division, growth promotion, and regeneration. HGH is crucial to the growth of the human body. Globally, growth hormone insufficiency is becoming more and more common. Insufficient synthesis of growth hormone by the pituitary gland is a defining feature of growth hormone deficit (GHD).
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Turner Syndrome
Fastest Growth
Growth Hormone deficiency
Growth Rate
12.3% CAGR
Global Human Growth Hormone Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Human Growth Hormone Market Segments Analysis
Global Human Growth Hormone Market is segmented by Product, Application, Distribution Channel and region. Based on Product, the market is segmented into Long Acting and Others. Based on Application, the market is segmented into Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age and Other. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Specialty Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Application
As per categorization by application, the market is classified as growth hormone deficiency, prader-willi syndrome, turner syndrome, small for gestational age (SGA), and others. Among these, the turner syndrome earned the largest share and continues to dominate the market. The Turner Syndrome application is leading the global human growth hormone market due to increasing awareness and the necessity for early treatment to manage growth and developmental challenges associated with the syndrome. New developments in treatments with HGH for Turner Syndrome have enhanced the efficiency of the treatment, thus increasing its demand. In addition, there have been developments in recombinant DNA technology which have made it possible to produce more effective and safer HGH treatments, all of which have contributed to the growth of the market and further cemented the commanding position of Turner Syndrome.
Growth Hormone Deficiency (GHD) is set to be the fastest-growing segment in the global human growth hormone industry due to rising awareness and improved diagnostic rates. As medical knowledge and diagnosis capabilities escalate, a growing number of isolated cases of GHD are being diagnosed very early, and hence corrective action is taken on time. Moreover, development of recombinant HGH therapies has brought about safer and more efficient treatment options invigorating the market. Rising expenditure on healthcare systems, particularly in the developing regions, is also supporting the revenue share of treatment of GHD. Increased attention to long-term results, improvement of quality of life, and new methods of drug delivery systems provide additional growth for GHD within the market for HGH.
Analysis by Route of Administration
The intramuscular route of administration is currently dominating, according to the global human growth hormone market analysis, due to its established efficacy, rapid absorption, and durability in delivering consistent results. There have been advancements in the design of the assecurator and the methods of delivering the injections, which have increased the comfort and adherence of patients making intramuscular injections the method of choice by most physicians and patients. Furthermore, this route allows for accurate dosing and ensures that hormone levels are maintained at steady conditions which is very important in cases like growth hormone deficiency and Turner syndrome. However, although there are subcutaneous alternatives beginning to emerge, most people are accustomed to intramuscular injection and thus their performance over time allows intramuscular injections to remain the leading method for the administration of HGH, hence sustaining their leading market share.
The intravenous route of administration is projected to be the fastest-growing segment in the global human growth hormone market due to its high bioavailability and rapid therapeutic effect, which are essential for critically ill or acute patients requiring immediate hormone response. Intravenous administration of HGH is becoming better incorporated in clinical practice largely due to advances in infusion technology and improvement in safety measures. In addition, this administration method finds increasing applications in emergency and inpatient settings where critical speeds and precise treatments are required. Growing healthcare investments coupled with rising needs for tailored controlled therapies of HGH injections in particular are also supporting the use of the intravenous route.
Global Human Growth Hormone Market By Application (%)
To get detailed analysis on other segments, Request For Free Sample Report
Human Growth Hormone Market Regional Insights
North America leads the global human growth hormone market due to advanced healthcare infrastructure, high awareness, and extensive research and development initiatives. The region enjoys favorable regulations and high healthcare expenditure, which allows for early detection and access to HGH therapies. The concentration of pharmaceutical companies and the relentless advances in the methods of dispensing drugs also help consolidate North America's market leadership. Moreover, the increasing number of growth disorders, and the willingness to explore new treatment options, fuels growth. The region's propensity to develop therapies that place the patient at the center and the highly sophisticated medical equipment available in the region also serve to explain why North America still leads the HGH market.
The Asia Pacific region is the fastest growing in the global human growth hormone market outlook, driven by rising healthcare investments, increasing awareness of growth disorders, and expanding access to advanced medical treatments. The increasing pace of economic development in countries such as China, India, and Japan provide for higher healthcare expenditure, thus increasing the use of HGH therapies. Additionally, improvements in healthcare infrastructure and growing emphasis on pediatric care support earlier diagnosis and treatment of growth-related conditions. The region's large population base, coupled with initiatives to boost biotech innovation, attracts global pharmaceutical companies and accelerates market growth, positioning Asia Pacific as a critical player in the HGH market's expansion.
Global Human Growth Hormone Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Human Growth Hormone Market Dynamics
Human Growth Hormone Market Drivers
Growing Prevalence of Growth Disorders
- The growing prevalence of aberrations in growth patterns such as Turner syndrome and growth hormone deficiency, has been the primary factor affecting the demand for human growth hormone products globally. With increased knowledge, there is increased diagnosis at early stages leading to further increasing demand for high therapies. This proclivity, together with enhanced accessibility of health care, drives global human growth hormone market growth.
Advancements in Recombinant HGH Technology
- The safety and efficacy of HGH treatments have improved substantially due to advancements in recombinant DNA technology. Such developments allow for the accurate synthesis of hormones, improving the results achieved in patients and lowering the negative effects. This progress in technology pulls the healthcare practitioners and increases the market demand making recombinant HGH a key growth component of the market.
Human Growth Hormone Market Restraints
Availability of Alternative Therapies
- The availability of alternative treatments for growth disorders, such as non-hormonal therapies and lifestyle interventions, restrains the HGH market. Assuming equivalent benefits can be obtained without the need for hormone therapy, many patients and providers lean towards less invasive or cost-denominated options thus minimizing the demand for HGH therapies.
Public Misconceptions and Stigma
- Public misconceptions and stigma surrounding human growth hormone use can hinder global growth hormone market growth. The use of HGH therapy in Thailand and other countries is often perceived as unethical for many patients and even medical professionals. This may lead to lower patient engagement and shrink the market for legitimate anti-aging HGH therapy, curbing the market growth.
Request Free Customization of this report to help us to meet your business objectives.
Human Growth Hormone Market Competitive Landscape
The global human growth hormone market presents a hybrid competition between ‘old fashioned' big pharmaceuticals and ‘upstart' newcomers. Braun Medical, Inc., Genentech (a division of Roche), Pfizer, Merck KGaA and Novo Nordisk are amongst the key global players with a strong market share and innovation. These firms concentrate on novel recombinant methods and aggressive marketing to fortify their firms' positions. More factors of competition emerge with increased cooperation and formation of strategic alliances, in turn resulting in more progress made in HGH therapies.
Top Player's Company Profiles
- Novo Nordisk A/S (Denmark)
- Pfizer Inc. (USA)
- Eli Lilly and Company (USA)
- Merck KGaA (Germany)
- Genentech Inc. (USA)
- Ipsen S.A. (France)
- Ferring Pharmaceuticals (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sandoz International GmbH (Germany)
- Anhui Anke Biotechnology (Group) Co., Ltd. (China)
- GeneScience Pharmaceuticals Co., Ltd. (China)
- OPKO Health, Inc. (USA)
- Ascendis Pharma A/S (Denmark)
- EMD Serono Inc. (USA)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Strongbridge Biopharma (USA)
- LG Life Sciences (South Korea)
- Biopartners GmbH (Germany)
Recent Developments in Human Growth Hormone Market
- In August 2023, Genentech reported favorable outcomes of clinical studies for its innovative drug that enables growth in prepubertal children with growth hormone deficiency. In the results, height velocity improvements were significant when compared to the standard of care treatment, therefore allowing Genentech to build its product range and reinforce its market share.
- In September 2023, Novo Nordisk launched a new delivery device for its human growth hormone therapy, aimed at improving patient compliance and ease of use. This innovative device features a user-friendly design and personalized dosing options, addressing patient needs and enhancing Novo Nordisk's competitive edge in the HGH market.
- In October 2023, Ipsen S.A. has been granted the approval to introduce a new formulation of its growth hormone treatment, which aims at providing an extended-release profile of the drug. The purpose of this development is to lower the frequency of injections, thereby improving patient compliance with treatment regimens. Ipsen’s innovative solution shows the company’s dedication to the advancement of growth disorder treatment across the world.
Human Growth Hormone Key Market Trends
- Rising Demand for Personalized Treatment Approaches: The global human growth hormone market is on a trend of moving towards more personalized treatment approaches in particular dosing and delivery techniques. Progress in biotechnology means that healthcare professionals can now offer individualized growth hormone therapies which improve results as well as the patient’s experience.
- Growth of Home-Based Administration Solutions: There is a growing trend towards home-based administration of human growth hormone therapies. Modern technologies such as smart and user-friendly injection devices and telehealth support systems promote self-administration of medicines thereby making treatment accessible to a majority. This development contributes to the comfort and compliance of patients while also lowering the number of hospital visits, thereby increasing the reach of the HGH market.
Human Growth Hormone Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global human growth hormone industry is poised for substantial growth, driven by advances in treatment methodologies, increased awareness, and innovative recombinant technologies. The segmentation by application and route of administration highlights the diverse needs of patients, with Turner syndrome and growth hormone deficiency emerging as pivotal areas of focus.
There are regional dynamics in North America that are conducive to the expansion of the market considering the presence of a favorable healthcare infrastructure and the rapid growth of the Asia Pacific region. Leading companies' unwavering investment in R&D drives the treatment improvement efforts, addresses societal misunderstanding, and in the long run, enhances the management of growth disorders, patient care and the outcomes thereof.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 6.32 billion |
| Market size value in 2032 | USD 17.95 billion |
| Growth Rate | 12.3% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Human Growth Hormone Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Human Growth Hormone Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Human Growth Hormone Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Human Growth Hormone Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Human Growth Hormone Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Human Growth Hormone Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Human Growth Hormone Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
